Gujarat Inject (Kerala) Limited has gained momentum in the market following the implementation of its 10:1 stock split, with the stock touching a fresh 52-week high of ₹14.30 on the BSE on July 9, 2026. The stock has risen sharply over the past year, reflecting increased investor interest alongside the company’s improving financial performance and renewable energy expansion.
The company had revised the record date for the stock split to July 8, 2026. Under the corporate action, each equity share with a face value of ₹10 was subdivided into 10 equity shares of ₹1 each. While a stock split does not alter a company’s market capitalisation or the value of shareholders’ holdings, it generally improves affordability and trading liquidity by increasing the number of shares in circulation.
The corporate action follows a year of strong financial growth. For the quarter ended March 2026, Gujarat Inject reported revenue of ₹30.70 crore, up 624% year-on-year from ₹4.24 crore. Net profit increased to ₹1.64 crore from ₹0.07 crore in the corresponding quarter last year. For FY26, revenue rose to ₹36.32 crore from ₹19.05 crore, while net profit grew to ₹1.81 crore from ₹1.02 crore.
The company’s renewable energy business has also expanded through a series of solar module supply contracts. Recent orders include a ₹14.49 crore contract from Deon Energy Limited, a ₹1.07 crore order from Ottire Lifestyle Private Limited, and an earlier ₹6.07 crore solar module order announced in June. Together, these contracts exceed ₹21.6 crore and strengthen the company’s order pipeline.
Adding to the strategic transition, Gujarat Inject has proposed changing its name to Regenova Renewtech Limited, reflecting its growing focus on clean energy. With stronger financials, a growing renewable energy order book and improved trading liquidity following the stock split, the company has attracted increased market attention in recent sessions.
